drugset / Trial / NCT02906644

Combination Nicotine Patch / Lorcaserin for Smoking Cessation

NCT02906644

RandomizedParallel-groupDouble-blindTreatment

Summary

This study plans to compare the efficacy of the nicotine patch / lorcaserin combination treatment vs. the nicotine patch alone in terms of leading to a reduction in smoking behavior and withdrawal symptoms.

Timeline

Start
2016-11-08
Primary completion
2018-03-27
Completion
2018-10-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Lorcaserin Small molecule 10 mg
Subject nicotine patch Unknown 21 mg Topical

Indications